Literature DB >> 16939881

PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs.

Hyun-Joung Lim1, Seahyoung Lee, Kuy-Sook Lee, Jin-Hee Park, Yangsoo Jang, Eun Jig Lee, Hyun-Young Park.   

Abstract

The purpose of the present study was to determine the role of peroxisome proliferator-activated receptor gamma (PPARgamma) activation in smooth muscle cell (SMC) derived form cell formation. Wild and mutant type PPARgamma were delivered by adenovirus then activated with troglitazone. The result of Oil Red O staining and FACS analysis showed that PPARgamma activation induced lipid accumulation in rVSMCs. Furthermore, PPARgamma activation reduced SMC marker genes such as alpha-actin while induced adipocyte differentiation marker genes and lipid metabolism-related genes as evidenced by RT-PCR and fluorescent immunocytochemistry. All these data demonstrate that PPARgamma activation can drive foam cell like change in rVSMCs. Our results strongly suggest that PPARgamma expression induces CD36 expression and adipocyte differentiation gene activation in the process of atherosclerosis and might be one of the crucial events in SMC derived foam cell formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939881     DOI: 10.1016/j.prostaglandins.2006.06.006

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  30 in total

1.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.

Authors:  Wei Li; Maria Febbraio; Sekhar P Reddy; Dae-Yeul Yu; Masayuki Yamamoto; Roy L Silverstein
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

Review 2.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

3.  CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia.

Authors:  Hong Yue; Maria Febbraio; Philip A Klenotic; David J Kennedy; Yueheng Wu; Shaoxian Chen; Amira F Gohara; Oliver Li; Adam Belcher; Bin Kuang; Thomas M McIntyre; Roy L Silverstein; Wei Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

4.  Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.

Authors:  Venkat Vangaveti; Bernhard T Baune; R Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 5.  A novel model of cholesterol efflux from lipid-loaded cells.

Authors:  Di-xian Luo; De-liang Cao; Yan Xiong; Xu-hong Peng; Duan-fang Liao
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

6.  Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease.

Authors:  Sherry Zhang; Chunxia Lu; Arun K Das; Anil K Pasupulati; Ram K Menon
Journal:  Growth Horm IGF Res       Date:  2018-10-04       Impact factor: 2.372

7.  Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.

Authors:  Wenqian Fang; Zhiyong Deng; Feriel Benadjaoud; Chongzhe Yang; Guo-Ping Shi
Journal:  Transl Res       Date:  2020-05-11       Impact factor: 7.012

Review 8.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 9.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

10.  The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli.

Authors:  Denise L Cecil; C Thomas G Appleton; Monika D Polewski; John S Mort; Ann Marie Schmidt; Alison Bendele; Frank Beier; Robert Terkeltaub
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.